Early and Sustained Clinical Benefits of Benralizumab in Severe Eosinophilic Asthma: Findings from the ORBE II Study.
Saved in:
| Title: | Early and Sustained Clinical Benefits of Benralizumab in Severe Eosinophilic Asthma: Findings from the ORBE II Study. |
|---|---|
| Authors: | Ausín P; Pulmonology Department, Hospital del Mar, 08003 Barcelona, Spain., Navarrete-Rouco ME; Pharmacy Department, Hospital del Mar, 08003 Barcelona, Spain., Carazo L; Pulmonology Department, Complejo Asistencial Universitario de León, 24071 León, Spain., Sanchez-Trincado JL; Medical Department, AstraZeneca Farmacéutica S.A., 28050 Madrid, Spain., Luzon E; Medical Department, AstraZeneca Farmacéutica S.A., 28050 Madrid, Spain., Nuevo J; Medical Department, AstraZeneca Farmacéutica S.A., 28050 Madrid, Spain., Santín M; Medical Department, AstraZeneca Farmacéutica S.A., 28050 Madrid, Spain., Sánchez J; Medical Department, AstraZeneca Farmacéutica S.A., 28050 Madrid, Spain., Padilla-Galo A; Pulmonology Department, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain. |
| Source: | Journal of clinical medicine [J Clin Med] 2025 Apr 26; Vol. 14 (9). Date of Electronic Publication: 2025 Apr 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2077-0383 |
|---|---|
| DOI: | 10.3390/jcm14093011 |
